Literature DB >> 22209840

A new dic(7;12)(p12.21;p12.2) and i(12)(q10) during the lymphoid blast crisis of patient with Ph+ chronic myeloid leukemia.

Fábio Morato de Oliveira1, Leonardo de Carvalho Palma, Roberto Passetto Falcão, Belinda Pinto Simões.   

Abstract

Chronic myelogenous leukemia (CML) is a common myeloproliferative disease that is characterized by the clonal expansion of marrow stem cells, and is associated with the Philadelphia chromosome. As the disease progresses, additional chromosome abnormalities may arise. The prognostic impact of secondary chromosomal abnormalities in CML is complex, heterogeneous, and sometimes related to previous treatment. Here, we describe a CML patient in lymphoid blast crisis associated with a new chromosomal abnormality identified, dic(7;12)(p12.21;p12.2) and i(12)(q10) using classical cytogenetics and spectral karyotype analysis. To the best of our knowledge, this is the first report of t(7;12)(p11.1;q11.1) and i(12)(q10) in a CML patient with lymphoid evolution.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22209840     DOI: 10.1007/s12032-011-0142-3

Source DB:  PubMed          Journal:  Med Oncol        ISSN: 1357-0560            Impact factor:   3.064


  21 in total

Review 1.  The biology of CML blast crisis.

Authors:  Bruno Calabretta; Danilo Perrotti
Journal:  Blood       Date:  2004-02-24       Impact factor: 22.113

2.  Segmental amplification of MLL gene associated with high expression of AURKA and AURKB genes in a case of acute monoblastic leukemia with complex karyotype.

Authors:  Fábio Morato de Oliveira; Antônio Roberto Lucena-Araújo; Sabrina D Leite-Cueva; Guilherme Augusto S Santos; Eduardo M Rego; Roberto P Falcão
Journal:  Cancer Genet Cytogenet       Date:  2010-04-01

3.  Interphase fluorescence in situ hybridization analysis: a study using centromeric probes 7, 8, and 12.

Authors:  L Zhao; Z Khan; K J Hayes; A B Glassman
Journal:  Ann Clin Lab Sci       Date:  1998 Jan-Feb       Impact factor: 1.256

Review 4.  Chromosome abnormalities in CML.

Authors:  A Hagemeijer
Journal:  Baillieres Clin Haematol       Date:  1987-12

5.  Value of cytogenetic studies in prediction of acute phase CML.

Authors:  A E Watmore; A M Potter; R J Sokol; J K Wood
Journal:  Cancer Genet Cytogenet       Date:  1985-01-15

Review 6.  Monosomy 7 and 7q--associated with myeloid malignancy.

Authors:  E Johnson; F E Cotter
Journal:  Blood Rev       Date:  1997-03       Impact factor: 8.250

7.  Telomere length shortening is associated with disease evolution in chronic myelogenous leukemia.

Authors:  J Boultwood; C Fidler; P Shepherd; F Watkins; J Snowball; S Haynes; R Kusec; A Gaiger; T J Littlewood; A J Peniket; J S Wainscoat
Journal:  Am J Hematol       Date:  1999-05       Impact factor: 10.047

Review 8.  ETV6: a versatile player in leukemogenesis.

Authors:  Stefan K Bohlander
Journal:  Semin Cancer Biol       Date:  2005-06       Impact factor: 15.707

9.  Determination of secondary chromosomal aberrations of chronic myelocytic leukemia.

Authors:  Ying Wang; Vicki L Hopwood; Peter Hu; Alan Lennon; Julie Osterberger; Armand Glassman
Journal:  Cancer Genet Cytogenet       Date:  2004-08

10.  Karyotypic evolution in Ph-positive chronic myeloid leukemia in relation to management and disease progression.

Authors:  B Swolin; A Weinfeld; J Westin; J Waldenström; B Magnusson
Journal:  Cancer Genet Cytogenet       Date:  1985-09
View more
  2 in total

Review 1.  Genetic events other than BCR-ABL1.

Authors:  Paolo Neviani
Journal:  Curr Hematol Malig Rep       Date:  2014-03       Impact factor: 3.952

2.  Previously Unreported Chromosomal Aberrations of t(3;3)(q29;q23), t(4;11)(q21;q23), and t(11;18)(q10;q10) in a Patient with Accelerated Phase Ph+ CML.

Authors:  Cigdem Aydin; Zafer Cetin; Ozan Salim; Orhan Kemal Yucel; Levent Undar; Sibel Berker Karauzum
Journal:  Case Rep Genet       Date:  2014-02-23
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.